Cancer Microenvironment and Therapeutic Implications [electronic resource] : Tumor Pathophysiology Mechanisms and Therapeutic Strategies / edited by Gianfranco Baronzio, Gianfranco Fiorentini, Christopher R. Cogle.

Call Number
614.5999
Title
Cancer Microenvironment and Therapeutic Implications Tumor Pathophysiology Mechanisms and Therapeutic Strategies / edited by Gianfranco Baronzio, Gianfranco Fiorentini, Christopher R. Cogle.
Edition
1.
Physical Description
XVI, 242 p. online resource.
Contents
Tumor Physiopathology and Microenvironment Genesis -- Inflammation and Carcinogenesis: A Change in the Metabolic Process -- Tumor Microenvironment: Aspects of Stromal-Parenchymal Interaction -- Significance of Tumor Microenvironment on the Genesis of: Interstitial Fluid, Angiogenesis, Haemostatic/Haemorheologic Abnormalities. Pathogenesis and Therapeutic Aspects -- Cancer, Stem Cells and the Neoplastic Niche -- Tumor Microenvironment, Therapeutic Perspectives and Strategies for Normalization -- Barriers to Drug Delivery in Cancer: Clinical Implications -- Hypoxia, Hyperthermia, Chemotherapy: Interactions and Opportunities -- Effects of Molecularly Targeting Hypoxia in Oncology -- Significance of the Tumour Microenvironment in Radiotherapy -- Effects of Tumor Microenvironment on Immunity and Consequent Clinical Considerations -- Effects of Tumor Microenvironment on Hyperthermia, Photodynamic and Nanotherapy -- Targeting Tumour Vascularization from Bench to Bedside: Suggestions for Combination with Hyperthermia -- New Indications for Established Drugs Able to Modify Tumour-Host Interactions.
Summary
In the post-genomic era, cancer is a genetic disease. However, cancer genotype does not always equal cancer phenotype. Cancers with the same genetic abnormalities don’t always behave the same. Understanding and eradicating cancers will require an appreciation for cancer’s ecology. This book is the first to comprehensively explore and critically appraise cancer microenvironments and host interactions with an eye towards exploiting our understanding for new treatments. The team of contributors share amongst them impressive experiences at the laboratory bench and in the clinic. These physician-scientists have dedicated themselves to the tension between the urgency for cures and the technical challenges of discovery. The target audience includes clinical oncologists, clinical hematologists, research oncologists, research hematologists, immunologists, stem cell researchers, oncology and hematology fellows (trainees), oncology educators (graduate and undergraduate levels), and course book for graduate students and undergraduate students.
Added Author
Baronzio, Gianfranco. editor.
Fiorentini, Gianfranco. editor.
Cogle, Christopher R. editor.
SpringerLink (Online service)
Subject
MEDICINE.
CANCER RESEARCH.
ONCOLOGY.
PATHOLOGY.
Biomedicine.
Cancer Research.
Oncology.
Pathology.
Multimedia
  • Libraries with this item
Total Ratings: 0
No records found to display.
 
 
 
03886nam a22005175i 4500
001
 
 
vtls001568277
003
 
 
VRT
005
 
 
20170831182500.0
007
 
 
cr nn 008mamaa
008
 
 
170831s2009    ne |    s    |||| 0|eng d
020
$a 9781402095764 $9 978-1-4020-9576-4
024
7
$a 10.1007/978-1-4020-9576-4 $2 doi
035
$a (DE-He213)978-1-4020-9576-4
039
9
$a 201708311825 $b santha $y 201708311319 $z vjs2012
050
4
$a RC261-271
072
7
$a MJCL $2 bicssc
072
7
$a MED062000 $2 bisacsh
082
0
4
$a 614.5999 $2 23
245
1
0
$a Cancer Microenvironment and Therapeutic Implications $h [electronic resource] : $b Tumor Pathophysiology Mechanisms and Therapeutic Strategies / $c edited by Gianfranco Baronzio, Gianfranco Fiorentini, Christopher R. Cogle.
250
$a 1.
264
1
$a Dordrecht : $b Springer Netherlands, $c 2009.
300
$a XVI, 242 p. $b online resource.
336
$a text $b txt $2 rdacontent
337
$a computer $b c $2 rdamedia
338
$a online resource $b cr $2 rdacarrier
347
$a text file $b PDF $2 rda
505
0
$a Tumor Physiopathology and Microenvironment Genesis -- Inflammation and Carcinogenesis: A Change in the Metabolic Process -- Tumor Microenvironment: Aspects of Stromal-Parenchymal Interaction -- Significance of Tumor Microenvironment on the Genesis of: Interstitial Fluid, Angiogenesis, Haemostatic/Haemorheologic Abnormalities. Pathogenesis and Therapeutic Aspects -- Cancer, Stem Cells and the Neoplastic Niche -- Tumor Microenvironment, Therapeutic Perspectives and Strategies for Normalization -- Barriers to Drug Delivery in Cancer: Clinical Implications -- Hypoxia, Hyperthermia, Chemotherapy: Interactions and Opportunities -- Effects of Molecularly Targeting Hypoxia in Oncology -- Significance of the Tumour Microenvironment in Radiotherapy -- Effects of Tumor Microenvironment on Immunity and Consequent Clinical Considerations -- Effects of Tumor Microenvironment on Hyperthermia, Photodynamic and Nanotherapy -- Targeting Tumour Vascularization from Bench to Bedside: Suggestions for Combination with Hyperthermia -- New Indications for Established Drugs Able to Modify Tumour-Host Interactions.
520
$a In the post-genomic era, cancer is a genetic disease. However, cancer genotype does not always equal cancer phenotype. Cancers with the same genetic abnormalities don’t always behave the same. Understanding and eradicating cancers will require an appreciation for cancer’s ecology. This book is the first to comprehensively explore and critically appraise cancer microenvironments and host interactions with an eye towards exploiting our understanding for new treatments. The team of contributors share amongst them impressive experiences at the laboratory bench and in the clinic. These physician-scientists have dedicated themselves to the tension between the urgency for cures and the technical challenges of discovery. The target audience includes clinical oncologists, clinical hematologists, research oncologists, research hematologists, immunologists, stem cell researchers, oncology and hematology fellows (trainees), oncology educators (graduate and undergraduate levels), and course book for graduate students and undergraduate students.
650
0
$a MEDICINE.
650
0
$a CANCER RESEARCH.
650
0
$a ONCOLOGY.
650
0
$a PATHOLOGY.
650
1
4
$a Biomedicine.
650
2
4
$a Cancer Research.
650
2
4
$a Oncology.
650
2
4
$a Pathology.
700
1
$a Baronzio, Gianfranco. $e editor.
700
1
$a Fiorentini, Gianfranco. $e editor.
700
1
$a Cogle, Christopher R. $e editor.
710
2
$a SpringerLink (Online service)
773
0
$t Springer eBooks
776
0
8
$i Printed edition: $z 9781402095757
856
4
0
$u http://dx.doi.org/10.1007/978-1-4020-9576-4
912
$a ZDB-2-SBL
950
$a Biomedical and Life Sciences (Springer-11642)
999
$a VIRTUA               
No Reviews to Display
Summary
In the post-genomic era, cancer is a genetic disease. However, cancer genotype does not always equal cancer phenotype. Cancers with the same genetic abnormalities don’t always behave the same. Understanding and eradicating cancers will require an appreciation for cancer’s ecology. This book is the first to comprehensively explore and critically appraise cancer microenvironments and host interactions with an eye towards exploiting our understanding for new treatments. The team of contributors share amongst them impressive experiences at the laboratory bench and in the clinic. These physician-scientists have dedicated themselves to the tension between the urgency for cures and the technical challenges of discovery. The target audience includes clinical oncologists, clinical hematologists, research oncologists, research hematologists, immunologists, stem cell researchers, oncology and hematology fellows (trainees), oncology educators (graduate and undergraduate levels), and course book for graduate students and undergraduate students.
Contents
Tumor Physiopathology and Microenvironment Genesis -- Inflammation and Carcinogenesis: A Change in the Metabolic Process -- Tumor Microenvironment: Aspects of Stromal-Parenchymal Interaction -- Significance of Tumor Microenvironment on the Genesis of: Interstitial Fluid, Angiogenesis, Haemostatic/Haemorheologic Abnormalities. Pathogenesis and Therapeutic Aspects -- Cancer, Stem Cells and the Neoplastic Niche -- Tumor Microenvironment, Therapeutic Perspectives and Strategies for Normalization -- Barriers to Drug Delivery in Cancer: Clinical Implications -- Hypoxia, Hyperthermia, Chemotherapy: Interactions and Opportunities -- Effects of Molecularly Targeting Hypoxia in Oncology -- Significance of the Tumour Microenvironment in Radiotherapy -- Effects of Tumor Microenvironment on Immunity and Consequent Clinical Considerations -- Effects of Tumor Microenvironment on Hyperthermia, Photodynamic and Nanotherapy -- Targeting Tumour Vascularization from Bench to Bedside: Suggestions for Combination with Hyperthermia -- New Indications for Established Drugs Able to Modify Tumour-Host Interactions.
Subject
MEDICINE.
CANCER RESEARCH.
ONCOLOGY.
PATHOLOGY.
Biomedicine.
Cancer Research.
Oncology.
Pathology.
Multimedia